Streckfus C F, Johnson R B, Nick T, Tsao A, Tucci M
Department of Diagnostic Sciences, University of Mississippi Medical Center, School of Dentistry, Jackson, USA.
J Gerontol A Biol Sci Med Sci. 1997 Nov;52(6):M343-51. doi: 10.1093/gerona/52a.6.m343.
Osteoporosis is an age-related metabolic bone disease characterized by decreased mass and increased susceptibility to fracture. The literature suggests a relationship between oral bone loss and skeletal osteoporosis; however, most studies have produced conflicting results. The purpose of this study was to determine if a relationship exists among alveolar bone loss, alveolar bone density, second metacarpal density, salivary and gingival crevicular fluid interleukin 6 (IL-6), and IL-8 concentrations in premenopausal and postmenopausal healthy women receiving estrogen therapy.
Twenty-eight healthy women (aged 23-78) were evaluated for this study. A vertical bitewing and hand radiographs were taken, and the subjects were evaluated for the presence of active periodontitis. The bitewing and hand radiographs were digitized, and measurements were made from the cemento-enamel junction to the alveolar crest from both arches. Bone density was evaluated in the maxillary and mandibular alveolar process and at the mid-shaft of the second metacarpal. Percent cortical area and the moment of inertia measurements were also determined. Stimulated whole saliva was collected for a 5-min period using a cube of paraffin as a stimulant and was analyzed for total protein by a colorimetric reaction and IL-6 and IL-8 by ELISA.
The results of the study showed that postmenopausal women on estrogen therapy had more alveolar bone loss, more missing teeth, and reduced alveolar and second metacarpal bone density than premenopausal women. In addition, postmenopausal women on estrogen therapy had higher salivary IL-6 concentrations than premenopausal women. Alveolar bone densities were also strongly correlated to second metacarpal densities.
The results of the study suggest that changes in alveolar bone density and levels of bone resorptive cytokines in saliva may be secondary to changes in menopausal status. These changes may predispose loss of alveolar bone with resultant loss of teeth.
骨质疏松症是一种与年龄相关的代谢性骨病,其特征是骨量减少和骨折易感性增加。文献表明口腔骨质流失与骨骼骨质疏松之间存在关联;然而,大多数研究结果相互矛盾。本研究的目的是确定接受雌激素治疗的绝经前和绝经后健康女性的牙槽骨丢失、牙槽骨密度、第二掌骨密度、唾液和龈沟液白细胞介素6(IL-6)以及IL-8浓度之间是否存在关联。
本研究对28名健康女性(年龄23 - 78岁)进行了评估。拍摄了垂直咬合翼片和手部X光片,并对受试者是否存在活动性牙周炎进行了评估。将咬合翼片和手部X光片数字化,并从两个牙弓的牙骨质 - 釉质界至牙槽嵴进行测量。评估上颌和下颌牙槽突以及第二掌骨中轴的骨密度。还测定了皮质面积百分比和惯性矩测量值。使用一块石蜡作为刺激物,收集5分钟的刺激性全唾液,通过比色反应分析总蛋白,并通过酶联免疫吸附测定法分析IL-6和IL-8。
研究结果表明,接受雌激素治疗的绝经后女性比绝经前女性有更多的牙槽骨丢失、更多的牙齿缺失,以及更低的牙槽骨和第二掌骨密度。此外,接受雌激素治疗的绝经后女性唾液中IL-6浓度高于绝经前女性。牙槽骨密度与第二掌骨密度也密切相关。
研究结果表明,牙槽骨密度的变化和唾液中骨吸收细胞因子水平的变化可能是绝经状态变化的继发结果。这些变化可能使牙槽骨丢失,进而导致牙齿缺失。